IL102858A - Pentafluoroethyl peptide derivatives as orally - active elastase inhibitors their preparation and pharmaceutical compositions containing them - Google Patents

Pentafluoroethyl peptide derivatives as orally - active elastase inhibitors their preparation and pharmaceutical compositions containing them

Info

Publication number
IL102858A
IL102858A IL10285892A IL10285892A IL102858A IL 102858 A IL102858 A IL 102858A IL 10285892 A IL10285892 A IL 10285892A IL 10285892 A IL10285892 A IL 10285892A IL 102858 A IL102858 A IL 102858A
Authority
IL
Israel
Prior art keywords
alkyl
val
ala
group
cycloalkyl
Prior art date
Application number
IL10285892A
Other languages
English (en)
Other versions
IL102858A0 (en
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of IL102858A0 publication Critical patent/IL102858A0/xx
Publication of IL102858A publication Critical patent/IL102858A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0827—Tripeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Rheumatology (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
IL10285892A 1991-08-22 1992-08-18 Pentafluoroethyl peptide derivatives as orally - active elastase inhibitors their preparation and pharmaceutical compositions containing them IL102858A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US74860791A 1991-08-22 1991-08-22

Publications (2)

Publication Number Publication Date
IL102858A0 IL102858A0 (en) 1993-01-31
IL102858A true IL102858A (en) 1998-12-27

Family

ID=25010166

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10285892A IL102858A (en) 1991-08-22 1992-08-18 Pentafluoroethyl peptide derivatives as orally - active elastase inhibitors their preparation and pharmaceutical compositions containing them

Country Status (16)

Country Link
EP (1) EP0529568B1 (fr)
JP (1) JP3311392B2 (fr)
KR (1) KR100242046B1 (fr)
AT (1) ATE147756T1 (fr)
AU (1) AU655831B2 (fr)
CA (1) CA2076307C (fr)
DE (1) DE69216713T2 (fr)
DK (1) DK0529568T3 (fr)
ES (1) ES2099186T3 (fr)
FI (1) FI923787A7 (fr)
GR (1) GR3022915T3 (fr)
HU (1) HU208703B (fr)
IL (1) IL102858A (fr)
NO (1) NO308999B1 (fr)
NZ (1) NZ243998A (fr)
ZA (1) ZA926185B (fr)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5714470A (en) * 1991-08-22 1998-02-03 Merrell Pharmaceuticals, Inc. Orally-active elastase inhibitors
AU671850B2 (en) * 1992-07-29 1996-09-12 Merrell Dow Pharmaceuticals Inc. Peptide lung surfactants and therapeutic combinations
AU664112B2 (en) * 1992-07-31 1995-11-02 Merrell Dow Pharmaceuticals Inc. Synthetic peptide lung surfactants having covalently bonded antioxidants
US5977074A (en) * 1993-10-01 1999-11-02 Merrell Pharmaceuticals, Inc. Inhibitors of β-amyloid protein production
US5436229A (en) * 1994-03-04 1995-07-25 Eli Lilly And Company Bisulfite adducts of arginine aldehydes
US5726159A (en) * 1994-03-04 1998-03-10 Eli Lilly And Company Antithrombotic agents
US5707966A (en) * 1994-03-04 1998-01-13 Eli Lilly And Company Antithrombotic agents
US5488037A (en) * 1994-03-04 1996-01-30 Eli Lilly And Company Antithrombotic agents
US5705487A (en) * 1994-03-04 1998-01-06 Eli Lilly And Company Antithrombotic agents
ZA951618B (en) * 1994-03-04 1996-08-27 Lilly Co Eli Antithrombotic agents
US5439888A (en) * 1994-03-04 1995-08-08 Eli Lilly And Company Antithrombotic agents
US5602101A (en) * 1994-03-04 1997-02-11 Eli Lilly And Company Antithrombotic agents
CA2143533A1 (fr) * 1994-03-04 1995-09-05 Kenneth D. Kurz Agents antithrombotiques
US5484772A (en) * 1994-03-04 1996-01-16 Eli Lilly And Company Antithrombotic agents
US5885967A (en) * 1994-03-04 1999-03-23 Eli Lilly And Company Antithrombotic agents
US5756810A (en) * 1994-03-11 1998-05-26 Pharmacopeia, Inc. Process of preparing 3-nitro benzoate compounds in lower alkanol
NZ284766A (en) * 1994-06-02 1998-06-26 Merrell Pharma Inc Perfluoro amino ketones; medicaments as elastase inhibitors
DE69522940T2 (de) * 1994-06-02 2002-04-04 Merrell Pharmaceuticals Inc., Cincinnati Acylierte enolderivate als vorläufdrogen von elastaseinhibitoren
EP0804465B1 (fr) * 1994-06-02 2003-08-06 Aventis Pharmaceuticals Inc. Nouveaux inhibitieurs d'elastase
US5618792A (en) * 1994-11-21 1997-04-08 Cortech, Inc. Substituted heterocyclic compounds useful as inhibitors of (serine proteases) human neutrophil elastase
US6001814A (en) * 1994-11-21 1999-12-14 Cortech Inc. Serine protease inhibitors
US6150334A (en) * 1994-11-21 2000-11-21 Cortech, Inc. Serine protease inhibitors-tripeptoid analogs
US6159938A (en) * 1994-11-21 2000-12-12 Cortech, Inc. Serine protease inhibitors comprising α-keto heterocycles
US5998379A (en) * 1994-11-21 1999-12-07 Cortech Inc. Serine protease inhibitors-proline analogs
US6015791A (en) * 1994-11-21 2000-01-18 Cortech Inc. Serine protease inhibitors-cycloheptane derivatives
US20020119985A1 (en) 1994-11-21 2002-08-29 Albert Gyorkos Serine protease inhibitors
US6100238A (en) * 1994-11-21 2000-08-08 Cortech Inc. Indole and tetrahydroisoquinoline containing Alpha-keto oxadiazoles as serine protease inhibitors
US6001811A (en) * 1994-11-21 1999-12-14 Cortech Inc. Serine protease inhibitors--N-substituted derivatives
US6001813A (en) * 1994-11-21 1999-12-14 Cortech Inc. Val-pro containing α-keto oxadiazoles as serine protease inhibitors
US5691368A (en) * 1995-01-11 1997-11-25 Hoechst Marion Roussel, Inc. Substituted oxazolidine calpain and/or cathepsin B inhibitors
US5914319A (en) * 1995-02-27 1999-06-22 Eli Lilly And Company Antithrombotic agents
US5710130A (en) * 1995-02-27 1998-01-20 Eli Lilly And Company Antithrombotic agents
KR100343553B1 (ko) * 1995-03-23 2002-10-31 에스케이케미칼주식회사 열가소성폴리에테르에스테르블록공중합체조성물
US5948886A (en) * 1996-11-20 1999-09-07 Hoechst Marion Roussel, Inc. Acylated enol derivatives of α-ketoesters and α-ketoamides
US6172044B1 (en) 1995-12-01 2001-01-09 Aventis Pharmaceuticals Inc. Acylated enol derivative of α-ketoesters and α-ketoamides
US6656910B2 (en) 1997-12-04 2003-12-02 Cortech, Inc. Serine protease inhibitors
DE69939740D1 (de) * 1998-05-20 2008-11-27 Expression Genetics Inc Laktose oder galaktose-polyethylen glykol-gepfropfte poly-l-lysin als genträger
WO2000032216A1 (fr) 1998-06-03 2000-06-08 Cortech Inc. Peptoide et non-peptoide contenant des exadiaoles alpha-ceto et utilises comme inhibiteurs de protease serine
EP2834216A1 (fr) 2012-04-04 2015-02-11 Catylix Inc. Modulateurs sélectifs de récepteur d'androgène

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0318318A1 (fr) * 1987-11-27 1989-05-31 Sensititre Limited Procédé d'essai d'urine et trousse
AU661270B2 (en) * 1990-03-05 1995-07-20 Cephalon, Inc. Chymotrypsin-like proteases and their inhibitors
CA2056453A1 (fr) * 1990-03-30 1991-10-01 Koji Kobayashi Derive de la 4h-3,1-benzoxazin-4-one

Also Published As

Publication number Publication date
AU2106592A (en) 1993-02-25
AU655831B2 (en) 1995-01-12
HUT62014A (en) 1993-03-29
ATE147756T1 (de) 1997-02-15
DK0529568T3 (da) 1997-02-03
NO308999B1 (no) 2000-11-27
DE69216713T2 (de) 1997-05-28
GR3022915T3 (en) 1997-06-30
JPH05213991A (ja) 1993-08-24
CA2076307C (fr) 2003-01-07
KR930004280A (ko) 1993-03-22
ZA926185B (en) 1993-03-01
HU208703B (en) 1993-12-28
JP3311392B2 (ja) 2002-08-05
FI923787A7 (fi) 1993-02-23
NZ243998A (en) 1994-11-25
DE69216713D1 (de) 1997-02-27
EP0529568B1 (fr) 1997-01-15
EP0529568A1 (fr) 1993-03-03
NO923280D0 (no) 1992-08-21
KR100242046B1 (ko) 2000-03-02
IL102858A0 (en) 1993-01-31
ES2099186T3 (es) 1997-05-16
FI923787A0 (fi) 1992-08-21
NO923280L (no) 1993-02-23
CA2076307A1 (fr) 1993-02-23

Similar Documents

Publication Publication Date Title
EP0529568B1 (fr) Nouveaux inhibiteurs de l'élastase actifs par voie orale
KR900008004B1 (ko) 펩티다제 억제물의 제조방법
AU772024B2 (en) Inhibitors of urokinase and blood vessel formation
JPH0759591B2 (ja) トリフルオロメチルケトン置換されたペプチド誘導体、その製法及びこれを含有するエラスタ−ゼ介在組織変性疾病の治療剤
JPH04253995A (ja) 新規ペプチド化合物
CA2024661A1 (fr) Inhibiteurs de la peptidase et de l'ismerase
NO861141L (no) Fremgangsmaate ved fremstilling av therapeutisk virksomme n,n[-dialkylguanidino-dipeptider.
NZ284766A (en) Perfluoro amino ketones; medicaments as elastase inhibitors
BG60739B2 (bg) Трипептиди,влияещи върху централната нервна система и метод за тяхното получаване
AU627156B2 (en) Amino acid derivatives
HU185320B (en) Process for producing biologically active encephaline analogous compounds
US5478811A (en) Orally-active elastase inhibitors
US5948886A (en) Acylated enol derivatives of α-ketoesters and α-ketoamides
EP0863916B1 (fr) Tripeptides de polyfluoroalkyle tryptophane inhibiteurs de thrombine
US6399599B1 (en) Substituted 2-oxo-1,4-diazacycloalkanes
US5714470A (en) Orally-active elastase inhibitors
HU185229B (en) Process for preparing pharmaceutically active peptides and acetates thereof
HU190915B (en) Process for preparing new tripeptide derivatives
EP0762887B1 (fr) Derives enol acyle utilisables comme promedicaments pour des inhibiteurs de l'elastase
PT91604A (pt) Process for preparing novel peptidase inhibitors of enzymes
EP0863915B1 (fr) Derives enol acyles de alpha-cetoesters et de alpha-cetoamides
JPWO2003082819A1 (ja) Ｎ−フェニル−ｎ−（４−ピペリジニル）アミド誘導体
HU187808B (en) Process for the preparation of n-bracket-carboxy-alkyl-bracket-prolina containing tripeptides
US6172044B1 (en) Acylated enol derivative of α-ketoesters and α-ketoamides
HU203115B (en) Process for producing peptides having renin inhibitting effect and pharmaceutical compositions comprising such compounds as active ingredient

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees